CD8A and Hepatitis: A recent analysis of phenotypic and transcriptional profiling of peripheral immune subsets of patients treated with ICIs and developing hepatitis showed the presence of activated monocytes and enhanced effector CD8+ T cells, compared to those without hepatitis and healthy controls.